All The Way To The Top: Diversity And Inclusion In Pharma Leadership

Policies, programs and strategies promoting diversity and inclusion are almost as ubiquitous in the pharmaceutical industry these days as environmental commitments. That reflects enormous cultural change over the last few generations, hastened in recent history by initiatives such as MeToo or Black Lives Matter.  

building blocks
• Source: Alamy

The challenge for companies today is to ensure their diversity and inclusion (D&I) efforts have real meaning, force and strategic weight. They must also show that D&I is not simply window-dressing or a defensive response to the cultural convulsions of recent years. That means embedding D&I sustainably in corporate values as not only the right but the rational and commercially astute thing to do.

D&I in leadership is where the rubber really hits the road. If pharmaceutical companies are serious about D&I, it needs...

More from Diversity & Inclusion

More from ESG